Samsung Ventures has made a strategic investment in Araris Biotech. The investment corporation, that was established to promote the development of new technologies, has invested in the company in an independent deal ahead of its
ATANIS Biotech, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase. iXLife, a French venture capital fund, co-led the round with US-based AllerFund, the first and
ITS Kanal Services acquired Künzli Group, a company active in the areas of wastewater disposal, rehabilitation and environmental management in western Switzerland. Based in Boswil, ITS Kanal Services is a full-service provider for the
Distalmotion, an international medical device company based in Lausanne, successfully closed the first tranche of its USD 150 million Series F financing round led by Revival Healthcare Capital. Founded and based in Lausanne, Distalmotion has the
Valaris Limited and its wholly-owned subsidiary, Valaris Finance Company, closed the private placement of USD 700 million in aggregate principal amount of 8.375% senior secured second lien notes due 2030 and a senior secured first lien five-year credit
The MELB Luxe group, owner of H. Moser & Cie, Hautlence and Precision Engineering, has invested in the capital of the Geneva workshop Agenhor. This minority investment is part of the integration process pursued by
Wenger Vieli strengthens its team with four new promotions: Jonas Bühlmann (senior associate to counsel, pictured left), Meltem Steudler (associate to senior associate, pictured centre), Sabine Taxer (associate to senior associate, pictured centre-right) and
Private equity investment firm Ardian, together with the management team led by CEO Agim Emruli, is investing in Swiss-based Flowable Holding and its subsidiaries (MFG). Headquartered in Bern, MFG specialises in services, software development and
Niederer Kraft Frey advised the underwriting syndicate led by Huatai Financial Holdings on the offering of global depositary receipts (GDRs) and SIX Swiss Exchange listing of Zheijang Supcon Technology under the China-Switzerland Stock Connect. Including
Kellerhals Carrard has reorganised and strengthened its Life Sciences team. It is now fully integrated into the value chain of its clients in the pharmaceutical, medical technology, health and nutrition sectors and is led by
